Eating Disorders News and Research

Latest Eating Disorders News and Research

Researchers receive NIMH grant to study new treatment for binge eating disorder

Steve Wonderlich, Chester Fritz Distinguished Professor of Clinical Neuroscience at the University School of Medicine and Health Sciences, North Dakota and Chair of Sanford's Eating Disorder Department, recently was awarded a National Institute of Mental Health (NIMH) grant to study a new treatment for binge eating disorder.

17 Mar 2014

Bayer and Onyx announce Phase 3 trial evaluating use of NEXAVAR for patients with HCC after local ablation

Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR® (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival.

11 Mar 2014

Frequent Facebook users not only share party pictures, but also greater risk of eating disorders

Frequent Facebook users might be sharing more than party pictures, vacation videos and shameless selfies - they also share a greater risk of eating disorders, according to a new study led by Florida State University researchers.

6 Mar 2014

GW SPHHS to hold public forum on prevalence and impact of eating disorders

The George Washington (GW) University School of Public Health and Health Services (SPHHS) will hold a public forum on February 25 that will address the prevalence and impact of eating disorders, especially on college campuses.

20 Feb 2014

Griffith University and Gold Coast Health program aims to help teens better manage diabetes

A Griffith University and Gold Coast Health program to help teenagers with diabetes better manage their condition has seen success on the Gold Coast.

29 Jan 2014

Study shows binge-eating disorder is associated with substantial lifelong impairments

Binge-eating disorder, designated in 2013 by the American Psychiatric Association as a diagnosis in its Diagnostic and Statistical Manual of Mental Disorders-V, is associated with substantial lifelong impairments comparable to those of bulimia nervosa, according to a recent World Health Organization study based on community epidemiological surveys conducted in 12 nations worldwide.

7 Jan 2014

Experts to share insights on the integration of science, psychotherapy and spirituality

Neuroscience is the new buzzword in the world of psychotherapy, yet distinguishing between true innovation and mere speculation can be difficult. In a new program at the 2014 iaedp Symposium in St. Petersburg, Florida (February 26-March 2), keynote speakers, Carolyn Costin, MFt, MA, MEd, CEDS and Joan Borysenko, PhD, will share their insights on the integration of science, psychotherapy and spirituality.

27 Dec 2013

Celgene subsidiary presents REVLIMID study results on lymphoma at ASH annual meeting

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG) today announced that results from two studies of REVLIMID (lenalidomide) combinations in patients with diffuse large B-cell lymphoma (DLBCL) were presented at the American Society of Hematology annual meeting in New Orleans, La.

11 Dec 2013

Janssen reports positive pivotal Phase 2 study data of siltuximab for Multicentric Castleman's Disease

Janssen Research & Development, LLC today announced positive results from a pivotal Phase 2 global registration study (MCD2001) suggesting siltuximab, an investigational compound, along with best supportive care, exhibited statistically significant efficacy and a tolerable safety profile compared with placebo and BSC in treating patients with the rare disorder Multicentric Castleman's Disease who are HIV-negative and human herpes virus 8-negative.

8 Dec 2013

Study identifies specific DCPR syndromes that could affect obesity

A study published in the current issue of Psychotherapy and Psychosomatics has applied diagnostic criteria for psychosomatic syndromes to a sample of patients with morbid obesity.

6 Dec 2013

"Appearance exposure" on Internet linked to body image disturbance among adolescent girls

"Appearance exposure" on the Internet has been linked to body image disturbance among adolescent girls. A new study that links specific Facebook activities, but not overall Facebook use to body dissatisfaction and a drive for thinness in teen girls is published in Cyberpsychology, Behavior, and Social Networking, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

4 Dec 2013

Study: Strong sense of ethnic identity can help Latina girls feel positive about appearance

A strong sense of ethnic identity can help Latina girls feel positive about their body and appearance, a new study concludes, even as this group slips further into dissatisfaction with themselves when compared to a media-filled world of unrealistic images of thin white women.

3 Dec 2013

Soligenix initiates orBec Phase 2 study for GI manifestations of chronic GVHD

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating orBec (oral beclomethasone 17,21-dipropionate or BDP) as a treatment for the gastrointestinal manifestations of chronic Graft-versus-Host disease.

2 Dec 2013

Social networking sites have positive effects on people with eating disorders

Social networking sites, such as Instagram have traditionally been believed to have a negative effect on people with eating disorders, but new research from Griffith’s School of Public Health has found that may not be the case.

30 Nov 2013

NEXAVAR tablets receive FDA approval for treatment of patients with thyroid cancer

Bayer HealthCare and Onyx Pharmaceuticals, Inc., an Amgen subsidiary, today announced that the U.S. Food and Drug Administration has approved a supplemental New Drug Application for the oral multi-kinase inhibitor NEXAVAR (sorafenib) tablets for the treatment of patients with locally recurrent or metastatic, progressive, differentiated thyroid carcinoma refractory to radioactive iodine treatment.

23 Nov 2013

Obese children could suffer step back in life expectancy by up to 10 years

In Mexico, overweight or obese children could suffer a step back in life expectancy by up to 10 years. According to the National Institute of Geography and Statistics (INEGI), the life expectancy in Mexico is of 73 years for women and 76 years for men.

21 Nov 2013

Study identifies patterns of brain activity associated with eating disorders

A growing body of evidence shows the impact of diet on brain function, and identifies patterns of brain activity associated with eating disorders such as binge eating and purging. The findings were presented at Neuroscience 2013, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.

14 Nov 2013

Helsinn grants exclusive commercialization rights to Chugai Pharma Marketing for anamorelin drug

Swiss-based Helsinn group has granted Chugai Pharma Marketing Ltd., a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd., exclusive commercialization rights to their innovative ghrelin receptor agonist, anamorelin, for the three major European pharma markets.

12 Nov 2013

Researchers highlight presence of specific antibodies that regulate appetite in obese patients

Obesity affects more than 15% of adults in France, and its constitutive mechanisms are still not completely explained. Normally, fine control of weight and food intake is coordinated by a specialised part of the brain (the hypothalamus).

31 Oct 2013

Psychotherapy: New treatment choice for anorexia nervosa

A large-scale study has now shown that adult women with anorexia whose disorder is not too severe can be treated successfully on an out-patient basis. Even after conclusion of therapy, they continue to make significant weight gains.

22 Oct 2013

Eating Disorders News and Research

Latest Eating Disorders News and Research

Researchers receive NIMH grant to study new treatment for binge eating disorder

Bayer and Onyx announce Phase 3 trial evaluating use of NEXAVAR for patients with HCC after local ablation

Frequent Facebook users not only share party pictures, but also greater risk of eating disorders

GW SPHHS to hold public forum on prevalence and impact of eating disorders

Griffith University and Gold Coast Health program aims to help teens better manage diabetes

Study shows binge-eating disorder is associated with substantial lifelong impairments

Experts to share insights on the integration of science, psychotherapy and spirituality

Celgene subsidiary presents REVLIMID study results on lymphoma at ASH annual meeting

Janssen reports positive pivotal Phase 2 study data of siltuximab for Multicentric Castleman's Disease

Study identifies specific DCPR syndromes that could affect obesity

"Appearance exposure" on Internet linked to body image disturbance among adolescent girls

Study: Strong sense of ethnic identity can help Latina girls feel positive about appearance

Soligenix initiates orBec Phase 2 study for GI manifestations of chronic GVHD

Social networking sites have positive effects on people with eating disorders

NEXAVAR tablets receive FDA approval for treatment of patients with thyroid cancer

Obese children could suffer step back in life expectancy by up to 10 years

Study identifies patterns of brain activity associated with eating disorders

Helsinn grants exclusive commercialization rights to Chugai Pharma Marketing for anamorelin drug

Researchers highlight presence of specific antibodies that regulate appetite in obese patients

Psychotherapy: New treatment choice for anorexia nervosa

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Eating Disorders News and Research

Latest Eating Disorders News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in